BOSCHI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 10.287
AS - Asia 5.529
EU - Europa 4.306
SA - Sud America 1.078
AF - Africa 106
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.340
Nazione #
US - Stati Uniti d'America 10.019
SG - Singapore 2.263
CN - Cina 1.591
IT - Italia 1.170
BR - Brasile 917
PL - Polonia 649
DE - Germania 599
HK - Hong Kong 537
UA - Ucraina 455
GB - Regno Unito 424
VN - Vietnam 351
TR - Turchia 290
FI - Finlandia 252
SE - Svezia 173
RU - Federazione Russa 158
CA - Canada 126
MX - Messico 123
ID - Indonesia 110
IN - India 97
NL - Olanda 76
FR - Francia 70
AR - Argentina 63
JP - Giappone 58
ZA - Sudafrica 58
AT - Austria 50
BE - Belgio 46
ES - Italia 44
BD - Bangladesh 42
AU - Australia 30
CH - Svizzera 28
IQ - Iraq 26
IR - Iran 26
CZ - Repubblica Ceca 24
EC - Ecuador 23
LT - Lituania 21
BG - Bulgaria 18
CO - Colombia 18
UZ - Uzbekistan 18
VE - Venezuela 17
TW - Taiwan 14
CL - Cile 12
HU - Ungheria 12
MA - Marocco 12
MY - Malesia 11
JO - Giordania 10
PK - Pakistan 10
KR - Corea 9
BO - Bolivia 8
KE - Kenya 8
PY - Paraguay 8
AZ - Azerbaigian 7
EG - Egitto 7
IL - Israele 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
KG - Kirghizistan 5
LB - Libano 5
PT - Portogallo 5
SA - Arabia Saudita 5
UY - Uruguay 5
DK - Danimarca 4
DZ - Algeria 4
GY - Guiana 4
IE - Irlanda 4
LV - Lettonia 4
PH - Filippine 4
TN - Tunisia 4
CR - Costa Rica 3
GA - Gabon 3
HN - Honduras 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
Totale 21.327
Città #
Singapore 1.257
Ashburn 986
Woodbridge 845
Fairfield 782
Warsaw 641
Chandler 572
Beijing 554
Santa Clara 547
Houston 544
Hong Kong 533
Ann Arbor 511
Jacksonville 483
Ferrara 323
Wilmington 303
Seattle 278
Cambridge 225
Los Angeles 210
Nanjing 191
Munich 184
Izmir 179
Dallas 177
Addison 159
New York 155
The Dalles 153
Princeton 144
Milan 124
Boardman 101
São Paulo 98
Ho Chi Minh City 96
Dearborn 82
Dong Ket 81
Shanghai 80
Helsinki 79
Jakarta 77
Mexico City 75
Buffalo 74
Turku 71
Hanoi 65
San Diego 64
London 57
Redwood City 57
Bologna 54
Tokyo 51
Nuremberg 50
Bremen 48
Brooklyn 46
Nanchang 44
Tianjin 42
Montreal 41
Shenyang 41
Brussels 40
Rome 38
Hefei 37
Boston 35
Denver 33
Stockholm 33
Chicago 32
Phoenix 32
Vienna 32
Toronto 31
Changsha 30
Chennai 30
Hebei 30
Orem 30
Moscow 29
Rio de Janeiro 29
San Francisco 27
Johannesburg 26
Poplar 26
Falls Church 24
Legnaro 24
Frankfurt am Main 23
Padova 23
Jiaxing 22
Kunming 22
Amsterdam 21
Atlanta 21
Augusta 21
Chengdu 19
Council Bluffs 19
Ankara 18
Brasília 18
Guangzhou 18
Monmouth Junction 17
Ningbo 17
Tashkent 17
Auburn Hills 16
Belo Horizonte 16
Brno 16
Genova 16
Mountain View 16
Mumbai 16
Norwalk 16
Wuhan 16
Zurich 16
Falkenstein 15
Washington 15
Charlotte 14
Columbus 14
Des Moines 14
Totale 13.794
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 465
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 350
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 288
Biodistribution of nanostructured lipid carriers: a tomographic study 277
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 275
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 274
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 250
LARAMED: A Laboratory for Radioisotopes of Medical Interest 239
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 238
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 235
A solvent-extraction module for cyclotron production of high-purity technetium-99m 223
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 214
YAP-(S)PET small animal scanner: Quantitative results 213
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 211
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 203
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 202
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 202
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 190
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 189
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 184
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 183
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 182
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 181
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 179
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 178
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 174
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 172
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 170
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 170
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 169
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 169
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 168
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 167
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 165
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 163
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 163
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 163
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 163
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 160
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 159
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 158
Extraction techniques of 99mTc from 100Mo Metal Target 157
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 157
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 153
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 152
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 151
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 150
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 150
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 147
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 146
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 145
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 145
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 144
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 144
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 141
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 141
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 139
Development of a β-spectrometer for 99gTc Activity Estimations 139
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 137
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 136
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 135
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 135
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 135
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 133
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 133
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 130
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 130
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 128
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 127
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 123
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 123
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 123
188W/188Re generator system and its therapeutic applicacions 122
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 119
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 119
Radioactive metal complexes comprising a tridentate complexing sequence 117
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 116
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 116
Production of 47Sc with natural vanadium targets: results of the PASTA project 115
Advances in the automation technologies within LARAMED project 115
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 114
Symmetric bis-substituted and asymmetric mono-substituted nitridotechnetium complexes with heterofunctionalized phosphinothiolate ligands 114
Perspectives on the use of liquid extraction for radioisotope purification 111
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 111
Recovery of Molybdenum Precursor Material in the Cyclotron-Based Technetium-99m Production Cycle 111
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 110
null 109
LARAMED: a LAboratoty of RAdioisotopes for MEDicine 109
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 108
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 107
Efficient preparation and stabilization of Re-188-MDP under physiological conditions 107
Might Re-188 be more effective for boosting therapy of breast cancer using the IART approach? 107
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 107
Quality control of Tc-99m radiopharmaceuticals: influence of the generator in growth time on the final radiochemical purity 106
New "3+1" chelating system for the development of therapeutic agents labeled with rhenium-188 104
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 104
LABELLING OF BIOTIN WITH 188Re 103
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 102
Totale 16.065
Categoria #
all - tutte 102.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.705
Totale 113.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.379 0 0 0 0 0 174 113 290 94 305 244 159
2021/20221.597 71 118 103 75 66 67 83 92 73 125 245 479
2022/20231.419 163 135 42 173 207 189 95 109 130 25 93 58
2023/20241.046 73 94 99 46 69 125 75 73 33 41 51 267
2024/20254.546 120 111 333 182 462 306 196 268 680 555 893 440
2025/20265.822 1.076 436 930 1.467 1.753 160 0 0 0 0 0 0
Totale 21.718